Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Payables (2020 - 2025)

Celularity (CELU) has disclosed Payables for 6 consecutive years, with $36.0 million as the latest value for Q4 2025.

  • For Q4 2025, Payables rose 39.58% year-over-year to $36.0 million; the TTM value through Dec 2025 reached $36.0 million, up 39.58%, while the annual FY2025 figure was $36.0 million, 39.58% up from the prior year.
  • Payables hit $36.0 million in Q4 2025 for Celularity, up from $28.9 million in the prior quarter.
  • Across five years, Payables topped out at $48.5 million in Q3 2022 and bottomed at $5.2 million in Q1 2021.
  • Average Payables over 5 years is $22.9 million, with a median of $26.4 million recorded in 2023.
  • Year-over-year, Payables surged 14989.52% in 2021 and then plummeted 67.3% in 2024.
  • Celularity's Payables stood at $9.3 million in 2021, then surged by 365.95% to $43.4 million in 2022, then dropped by 27.75% to $31.4 million in 2023, then decreased by 17.81% to $25.8 million in 2024, then skyrocketed by 39.58% to $36.0 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $36.0 million, $28.9 million, and $28.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.